BARCELONA — Tapas and tablets go hand in hand at the Mobile World Congress, the annual gathering of wireless executives, device makers and software peddlers who descend on this beautiful city to show off the latest and hottest developments in mobile technology.
They cover jobs at all skill levels, including hotel concierges, restaurant managers, teachers, I.T. specialists, business analysts, sales directors, account executives, orthopedics device salesmen, auditors and air-conditioning technicians.
Now, executives of device companies say the F.D.A. has gone too far in flexing its regulatory muscle, and they worry that a slower, tougher approval process in a weakened economy could chill investments and cripple innovation.
K. R. Sridhar, Bloom's co-founder and chief executive, said devices made by his company were generating electricity at a cost of 8 to 10 cents a kilowatt hour, using natural gas.
Contestants will make five-minute presentations before a panel of judges, which will include venture capitalists and executives from device makers and industrial design companies.
In addition to always working those words in our communications, we tried not to miss an opportunity to point the finger of blame for escalating health care costs at others: greedy doctors and hospital executives; medical device manufacturers, inventors of new whiz-bang diagnostic tools and even patients who demand the latest and most expensive drugs.
Stryker and its executives promoted devices known as OP-1 Implant and OP-1 Putty for use in a manner that was different from the use approved by the F.D.A., authorities said.
Art Collins Art Collins, chief executive of medical device maker Medtronic, ran through a list of devices his company makes to treat diseases from heart problems to diabetes to Parkinson's disease that have reached less than 20% of the patients Medtronic thinks could be helped.
"This is a more balanced approach that sends a positive signal to industry that the F.D.A. is engaged, listening and concerned," said William A. Hawkins, chief executive of the device maker Medtronic.
A former medical device executive claimed in a potential whistle-blower lawsuit that was unsealed this week that the makers of stents approved to treat digestive tract cancers had illegally marketed them for years to treat blocked blood vessels in other parts of the body.
LG's brass certainly thinks their Intel smartphone is viable — according to one of the Times' executive sources, the device could be released as soon this March.
